Prue E. Allan
Impact in
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
-
- PARP inhibition in cancer therapy
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Papers in
-
- Ovarian cancer diagnosis and treatment 10
-
- Breast Cancer Treatment Studies 1
- Co-authors
- Ian Campbell (5 shared papers)Sally M. Hunter (4 shared papers)Simone M. Rowley (5 shared papers)David D.L. Bowtell (4 shared papers)Kylie L. Gorringe (6 shared papers)Maria Doyle (4 shared papers)Georgina L. Ryland (3 shared papers)Georgia Chenevix‐Trench (3 shared papers)
- Journals
- The Journal of Pathology (2 papers)Clinical Cancer Research (1 paper)Nature Communications (1 paper)Modern Pathology (1 paper)Oncotarget (1 paper)
- Partner nations
- AustraliaCanadaUnited Kingdom
In The Last Decade
Prue E. Allan
12 papers receiving 787 citations
Peers
Comparison fields: 5 of 35
- Reproductive Medicine 557
- Oncology 101
- Drug Discovery 1
- Cancer Research 43
- Molecular Biology 102
Countries citing papers authored by Prue E. Allan
This map shows the geographic impact of Prue E. Allan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prue E. Allan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prue E. Allan more than expected).
Fields of papers citing papers by Prue E. Allan
This network shows the impact of papers produced by Prue E. Allan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prue E. Allan. The network helps show where Prue E. Allan may publish in the future.
Co-authors
The 25 scholars most cited alongside Prue E. Allan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 153 | |
| 2 | 2019 | 137 | |
| 3 | 2015 | 128 | |
| 4 | 2012 | 97 | |
| 5 | 2020 | 90 | |
| 6 | 2017 | 76 | |
| 7 | 2020 | 63 | |
| 8 | 2020 | 29 | |
| 9 | 2013 | 15 | |
| 10 | 2020 | 9 | |
| 11 | 2023 | 7 | |
| 12 | 2015 | 4 | |
| 13 | 2024 | 0 | |
| 14 | 2025 | 0 |
About Prue E. Allan
Prue E. Allan is a scholar working on Reproductive Medicine, Cancer Research, Oncology, Genetics and Artificial Intelligence, having authored 14 papers that have together received 808 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (10 papers), Breast Cancer Treatment Studies (1 paper), Cutaneous Melanoma Detection and Management (1 paper), BRCA gene mutations in cancer (1 paper) and AI in cancer detection (1 paper). The work is most often cited by research in Reproductive Medicine (557 citations), Oncology (101 citations), Drug Discovery (1 citation), Cancer Research (43 citations) and Molecular Biology (102 citations). Prue E. Allan has collaborated with scholars based in Australia, Canada and United Kingdom. Frequent co-authors include Ian Campbell, Sally M. Hunter, Simone M. Rowley, David D.L. Bowtell, Kylie L. Gorringe, Maria Doyle, Georgina L. Ryland, Georgia Chenevix‐Trench, Michael Christie and Jason Li. Their work appears in journals such as The Journal of Pathology, Clinical Cancer Research, Nature Communications, Modern Pathology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.